Syncom Formul.

{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "13.44",
    "chg": 0.25,
    "chgp": "1.9%",
    "dir": 1,
    "prev_price": "13.19",
    "mcapval": "1,253.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE312C01025",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "03:45 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "21.1 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Syncom Formulations (India) Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-syncom-formulations-india-ltd-4142384",
        "imagepath": "",
        "date": "2026-08-07 23:19:59",
        "description": "The next results date for Syncom Formulations (India) Ltd is scheduled for 11 August 2026...."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-4137799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SyncomFormulati_mojoScore_4137799.png",
        "date": "2026-08-05 10:10:55",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Syncom Formulations Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4129448",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyncomFormulati_valuationdot_4129448.png",
        "date": "2026-07-31 08:00:44",
        "description": "Syncom Formulations (India) Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating on key metrics such as price-to-earnings (P/E) and price-to-book value (P/BV). Despite a challenging year-to-date performance and a micro-cap status within the Pharmaceuticals & Biotechnology sector, the company’s improved valuation profile and robust return on capital employed (ROCE) suggest a potential opportunity for discerning investors."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-4120184",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyncomFormulati_mojoScore_4120184.png",
        "date": "2026-07-25 10:10:28",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Syncom Formulations Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-faces-bearish-momentum-amid-technical-downgrade-4117032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyncomFormulati_technicaldot_4117032.png",
        "date": "2026-07-23 08:03:19",
        "description": "Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating reflects growing concerns over its price momentum and technical health amid broader market pressures."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-4100643",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyncomFormulati_mojoScore_4100643.png",
        "date": "2026-07-14 10:11:27",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-4087349",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyncomFormulati_mojoScore_4087349.png",
        "date": "2026-07-03 10:11:16",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-4067070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SyncomFormulati_mojoScore_4067070.png",
        "date": "2026-06-22 10:12:49",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-4046387",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SyncomFormulati_mojoScore_4046387.png",
        "date": "2026-06-11 10:10:57",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      }
    ],
    "total": 284,
    "sid": "831770",
    "stock_news_url": "https://www.marketsmojo.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Corporate Action-Board to consider Dividend",
      "datetime": "06-Aug-2026",
      "details": "Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulation 2015 we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the company is scheduled to be held on Tuesday the 11th day of August 2026 at 4:00 P.M. at the Corporate office of the company to consider and recommend the Final Dividend on equity share of the Company for the Financial Year ended 31st March 2026 if any;",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations 2015 Read With SEBI (PIT) Regulations 2015 Regarding Intimation Of Holding The 2/2026-27 Board Meeting Scheduled To Be Held On Tuesday 11Th Day Of August 2026.",
      "datetime": "06-Aug-2026",
      "details": "Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday the 11th day of August 2026 at 4:00 P.M. (IST) at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "10-Jul-2026",
      "details": "Certificate for compliance of regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 30th June 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>3%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

When is the next results date for Syncom Formulations (India) Ltd?

2026-08-07 23:19:59

The next results date for Syncom Formulations (India) Ltd is scheduled for 11 August 2026....

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-08-05 10:10:55

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Syncom Formulations Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges

2026-07-31 08:00:44

Syncom Formulations (India) Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating on key metrics such as price-to-earnings (P/E) and price-to-book value (P/BV). Despite a challenging year-to-date performance and a micro-cap status within the Pharmaceuticals & Biotechnology sector, the company’s improved valuation profile and robust return on capital employed (ROCE) suggest a potential opportunity for discerning investors.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-07-25 10:10:28

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Syncom Formulations Faces Bearish Momentum Amid Technical Downgrade

2026-07-23 08:03:19

Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating reflects growing concerns over its price momentum and technical health amid broader market pressures.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-07-14 10:11:27

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-07-03 10:11:16

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-06-22 10:12:49

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-06-11 10:10:57

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

View All News